Median Technologies Launches Imaging Lab, Spearheading the Integration of iBiopsy® Artificial Intelligence Technologies Into iCRO Imaging Services for Oncology Trials
yahoo.com
news
2022-05-31 15:45:00

With Imaging Lab, Median will provide biopharmaceutical companies with new decision-making tools for clinical trials by leveraging images with data mining and Artificial Intelligence (AI) technologies from iBiopsy® and radiomics

Imaging Lab's solutions will support the pharmaceutical industry's paradigm shift towards therapies targeting patients with early-stage cancers

The Imaging Lab team will be exhibiting at the ASCO Annual Conference in Chicago, June 3-7, 2022, Median's booth #2098, Exhibit Hall A, McCormick place

SOPHIA ANTIPOLIS, France, May 31, 2022--(BUSINESS WIRE)--Regulatory News:

Median Technologies (Paris:ALMDT) announces that the company is expanding its portfolio of services with Imaging Lab, a new entity whose mission is to leverage AI, data mining, and radiomics technologies to exploit imaging data from clinical trials in oncology.
